Literature DB >> 22691257

Pentraxin 3 in children suffering from allergic rhinitis.

G L Marseglia1, M De Amici, S Leonardi, M Miraglia Del Giudice, A Salpietro, M La Rosa, D Caimmi, S Caimmi, A Licari, G Ciprandi.   

Abstract

Allergic disorders are typically characterized by an inflammatory response to allergen exposure. PTX3 behaves as an acute-phase response protein as there is a relationship between PTX3 plasma levels and disease severity. Therefore, this study was designed to investigate a possible role of PTX3 in children with allergic rhinitis. One hundred patients (28 females, 72 males, median age 11 years) were enrolled in the study. All patients were monosensitized: 43 (43%) to seasonal allergens (Graminaceae), 57 (57%) to perennial allergens (house dust mites, cat and dog epithelium, alternaria tenuis). Patients' blood samples for assessing serum PTX3 levels were performed during the spring. Children with rhinitis had higher PTX3 levels and there was a significant relationship between symptom severity and serum levels. Therefore, this study shows that PTX3 serum levels could be a reliable marker for symptom severity in children with allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691257

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  1 in total

1.  Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.

Authors:  Wei Ge; Hai-Lian Wang; Ruo-Peng Sun
Journal:  Eur J Pediatr       Date:  2013-08-21       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.